Real-time US versus CT determination of pubic arch interference for brachytherapy

PURPOSE: Part 1, to determine whether transrectal ultrasonography (US) enab les accurate determination of pubic arch interference (PAI) for prostate br achytherapy (PBT); part 2, to compare the accuracy of transrectal US with t hat of computed tomography (CT) for PAI determination; and part 3, to deter mine the cost savings of PAI determination with transrectal US versus that with CT. MATERIALS AND METHODS: Part 1. The pubic arch was identified intraoperative ly with transrectal US and compared with attempted needle passage (14 patie nts). Part 2: Planning CT with the patient supine was compared with plannin g transrectal US with patients in the dorsal lithotomy position (nine patie nts). Part 3: Cost savings were calculated for PAI determination with trans rectal US versus that with CT (32 patients per group). RESULTS: Part 1: Transrectal US accurately showed the pubic arch relative t o the prostate. Part 2: CT resulted in PAI overestimation by 11.8 mm. Part 3: Cost savings with transrectal US were $1,465 per patient. CONCLUSION: Transrectal US PAI determination is easily performed, intraoper atively useful, and accurate. CT can result in PAI overestimation. Reducing direct CT costs and the indirect costs of unnecessary hormonal therapy for false-positive PAI will reduce expense and improve patient care. Transrect al US should replace CT for PAI determination.